BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 4906375)

  • 1. Clinical experience of the treatment of drug-resistant pulmonary tuberculosis with rifampicin combined with ethambutol and capreomycin.
    Wäre M; Heinivaara O; Elo R; Tala E
    Scand J Respir Dis Suppl; 1969; 69():59-63. PubMed ID: 4906375
    [No Abstract]   [Full Text] [Related]  

  • 2. Capreomycin, ethambutol and rifampicin in apparently incurable pulmonary tuberculosis.
    Hellström PE; Repo UK
    Scand J Respir Dis Suppl; 1969; 69():69-74. PubMed ID: 4906377
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin.
    Radenbach KL
    Scand J Respir Dis Suppl; 1969; 69():43-53. PubMed ID: 4906373
    [No Abstract]   [Full Text] [Related]  

  • 4. The requirement of capreomycin, ethambutol and rifampicin in chronic pulmonary tuberculosis in Helsinki on the basis of resistance indications.
    Tani P
    Scand J Respir Dis Suppl; 1969; 69():15-6. PubMed ID: 4313500
    [No Abstract]   [Full Text] [Related]  

  • 5. The combined use of capreomycin and ethambutol in re-treatment of pulmonary tuberculosis.
    Donomae I
    Am Rev Respir Dis; 1968 Oct; 98(4):699-702. PubMed ID: 5677157
    [No Abstract]   [Full Text] [Related]  

  • 6. A national therapy project for drug resistant pulmonary tuberculosis.
    Øvreberg K; Bjartveit K
    Scand J Respir Dis; 1974; 55(4):218-28. PubMed ID: 4140569
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A; Raafat H; Siddiqui GM
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract]   [Full Text] [Related]  

  • 8. Capreomycin, ethambutol and rifampicin. Clinical experience in Manchester.
    Wilson TM
    Scand J Respir Dis Suppl; 1969; 69():33-42. PubMed ID: 4906372
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of isoniazid-resistant pulmonary tuberculosis with ethambutol, rifampicin and capreomycin: a co-operative study in England and Wales.
    Andrews RH; Jenkins PA; Marks J; Pines A; Selkon JB; Somner AR
    Tubercle; 1974 Jun; 55(2):105-13. PubMed ID: 4143450
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifampicin, ethambutol and capreomycin in pulmonary tuberculosis, previously treated with both first and second line drugs: the results of 2 years chemotherapy.
    Aquinas M; Citron KM
    Tubercle; 1972 Sep; 53(3):153-65. PubMed ID: 4116993
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifampicin and ethambutol in retreatment of chronic pulmonary tuberculosis.
    Wiman LG; Johansson R; Tegner KB
    Scand J Respir Dis; 1973; 54(5):255-63. PubMed ID: 4777378
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of daily followed by twice or once weekly regimens of ethambutol and rifampicin in retreatment of patients with pulmonary tuberculosis. The results at 1 year. A cooperative tuberculosis chemotherapy study in Poland.
    Tubercle; 1975 Mar; 56(1):1-26. PubMed ID: 1096388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pulmonary tuberculosis.
    Byrd RB; Kaplan PD; Gracey DR
    Chest; 1974 Nov; 66(5):560-7. PubMed ID: 4139002
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of intractable pulmonary tuberculosis: place of capreomycin in therapeutic programs with rifampicin and ethambutol].
    Oury M; Tuchais E; Norval C; Carbonnelle B; Leroux MF; Corre C; Parvery F
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):519-30. PubMed ID: 5510321
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
    Virchow C; Flemming J
    Acta Tuberc Pneumol Belg; 1969; 60(3):466-70. PubMed ID: 5371671
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses].
    Neumeyer D; Anschel R; Eule H; Fichtner K; Ganguin HG; Pickroth G
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):135-8. PubMed ID: 4491710
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary results of the Norwegian coordinated therapy project 1968-1969.
    Ovreberg K
    Scand J Respir Dis Suppl; 1969; 69():65-8. PubMed ID: 4906376
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experiences with capreomycin, ethambutol and rifampicin].
    Orlowski EH
    Prax Pneumol; 1969 Mar; 23(3):178-84. PubMed ID: 4888235
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
    Tricoire J; Marécaux L
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):226-41. PubMed ID: 5385585
    [No Abstract]   [Full Text] [Related]  

  • 20. Side effects of rifampicin. A clinical study.
    Mattson K
    Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.